Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Breakdown of Immune Tolerance in AIRE-Deficient Rats Induces a Severe Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy-like Autoimmune Disease.

Ossart J, Moreau A, Autrusseau E, Ménoret S, Martin JC, Besnard M, Ouisse LH, Tesson L, Flippe L, Kisand K, Peterson P, Hubert FX, Anegon I, Josien R, Guillonneau C.

J Immunol. 2018 Aug 1;201(3):874-887. doi: 10.4049/jimmunol.1701318. Epub 2018 Jun 29.

PMID:
29959280
2.

Generation of Immunodeficient Rats With Rag1 and Il2rg Gene Deletions and Human Tissue Grafting Models.

Ménoret S, Ouisse LH, Tesson L, Delbos F, Garnier D, Remy S, Usal C, Concordet JP, Giovannangeli C, Chenouard V, Brusselle L, Merieau E, Nerrière-Daguin V, Duteille F, Bellier-Waast F, Fraichard A, Nguyen TH, Anegon I.

Transplantation. 2018 Aug;102(8):1271-1278. doi: 10.1097/TP.0000000000002251.

PMID:
29688994
3.

CtIP fusion to Cas9 enhances transgene integration by homology-dependent repair.

Charpentier M, Khedher AHY, Menoret S, Brion A, Lamribet K, Dardillac E, Boix C, Perrouault L, Tesson L, Geny S, De Cian A, Itier JM, Anegon I, Lopez B, Giovannangeli C, Concordet JP.

Nat Commun. 2018 Mar 19;9(1):1133. doi: 10.1038/s41467-018-03475-7.

4.

Generation of gene-edited rats by delivery of CRISPR/Cas9 protein and donor DNA into intact zygotes using electroporation.

Remy S, Chenouard V, Tesson L, Usal C, Ménoret S, Brusselle L, Heslan JM, Nguyen TH, Bellien J, Merot J, De Cian A, Giovannangeli C, Concordet JP, Anegon I.

Sci Rep. 2017 Nov 29;7(1):16554. doi: 10.1038/s41598-017-16328-y.

5.

Advances in transgenic animal models and techniques.

Ménoret S, Tesson L, Remy S, Usal C, Ouisse LH, Brusselle L, Chenouard V, Anegon I.

Transgenic Res. 2017 Oct;26(5):703-708. doi: 10.1007/s11248-017-0038-x. Epub 2017 Aug 5.

PMID:
28780744
6.

Comparative Analysis of piggyBac, CRISPR/Cas9 and TALEN Mediated BAC Transgenesis in the Zygote for the Generation of Humanized SIRPA Rats.

Jung CJ, Ménoret S, Brusselle L, Tesson L, Usal C, Chenouard V, Remy S, Ouisse LH, Poirier N, Vanhove B, de Jong PJ, Anegon I.

Sci Rep. 2016 Aug 17;6:31455. doi: 10.1038/srep31455.

7.

A Rapid and Cost-Effective Method for Genotyping Genome-Edited Animals: A Heteroduplex Mobility Assay Using Microfluidic Capillary Electrophoresis.

Chenouard V, Brusselle L, Heslan JM, Remy S, Ménoret S, Usal C, Ouisse LH, NGuyen TH, Anegon I, Tesson L.

J Genet Genomics. 2016 May 20;43(5):341-8. doi: 10.1016/j.jgg.2016.04.005. Epub 2016 May 4.

PMID:
27209567
8.

Improved Genome Editing Efficiency and Flexibility Using Modified Oligonucleotides with TALEN and CRISPR-Cas9 Nucleases.

Renaud JB, Boix C, Charpentier M, De Cian A, Cochennec J, Duvernois-Berthet E, Perrouault L, Tesson L, Edouard J, Thinard R, Cherifi Y, Menoret S, Fontanière S, de Crozé N, Fraichard A, Sohm F, Anegon I, Concordet JP, Giovannangeli C.

Cell Rep. 2016 Mar 8;14(9):2263-2272. doi: 10.1016/j.celrep.2016.02.018. Epub 2016 Feb 25.

9.

Genome Editing in Rats Using TALE Nucleases.

Tesson L, Remy S, Ménoret S, Usal C, Thinard R, Savignard C, De Cian A, Giovannangeli C, Concordet JP, Anegon I.

Methods Mol Biol. 2016;1338:245-59. doi: 10.1007/978-1-4939-2932-0_18.

PMID:
26443226
10.

Homology-directed repair in rodent zygotes using Cas9 and TALEN engineered proteins.

Ménoret S, De Cian A, Tesson L, Remy S, Usal C, Boulé JB, Boix C, Fontanière S, Crénéguy A, Nguyen TH, Brusselle L, Thinard R, Gauguier D, Concordet JP, Cherifi Y, Fraichard A, Giovannangeli C, Anegon I.

Sci Rep. 2015 Oct 7;5:14410. doi: 10.1038/srep14410.

11.

IL-34 is a Treg-specific cytokine and mediates transplant tolerance.

Bézie S, Picarda E, Ossart J, Tesson L, Usal C, Renaudin K, Anegon I, Guillonneau C.

J Clin Invest. 2015 Oct 1;125(10):3952-64. doi: 10.1172/JCI81227. Epub 2015 Sep 21.

12.

Transgenic animals and genetic engineering techniques. Nantes, France, 2-3 July, 2015.

Ménoret S, Tesson L, Remy S, Usal C, Ouisse LH, Brusselle L, Chenouard V, Nguyen TH, David L, Anegon I.

Transgenic Res. 2015 Dec;24(6):1079-85. doi: 10.1007/s11248-015-9904-6. Epub 2015 Sep 10. No abstract available.

PMID:
26358113
13.

Efficient Generation of Myostatin Knock-Out Sheep Using CRISPR/Cas9 Technology and Microinjection into Zygotes.

Crispo M, Mulet AP, Tesson L, Barrera N, Cuadro F, dos Santos-Neto PC, Nguyen TH, Crénéguy A, Brusselle L, Anegón I, Menchaca A.

PLoS One. 2015 Aug 25;10(8):e0136690. doi: 10.1371/journal.pone.0136690. eCollection 2015.

14.

Fibrinogen-like protein 2/fibroleukin induces long-term allograft survival in a rat model through regulatory B cells.

Bézie S, Picarda E, Tesson L, Renaudin K, Durand J, Ménoret S, Mérieau E, Chiffoleau E, Guillonneau C, Caron L, Anegon I.

PLoS One. 2015 Mar 12;10(3):e0119686. doi: 10.1371/journal.pone.0119686. eCollection 2015.

15.

Codon swapping of zinc finger nucleases confers expression in primary cells and in vivo from a single lentiviral vector.

Abarrategui-Pontes C, Créneguy A, Thinard R, Fine EJ, Thepenier V, Fournier le RL, Cradick TJ, Bao G, Tesson L, Podevin G, Anegon I, Nguyen TH.

Curr Gene Ther. 2014;14(5):365-76.

PMID:
25687502
16.

Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy.

Larcher T, Lafoux A, Tesson L, Remy S, Thepenier V, François V, Le Guiner C, Goubin H, Dutilleul M, Guigand L, Toumaniantz G, De Cian A, Boix C, Renaud JB, Cherel Y, Giovannangeli C, Concordet JP, Anegon I, Huchet C.

PLoS One. 2014 Oct 13;9(10):e110371. doi: 10.1371/journal.pone.0110371. eCollection 2014.

17.

Efficient gene targeting by homology-directed repair in rat zygotes using TALE nucleases.

Remy S, Tesson L, Menoret S, Usal C, De Cian A, Thepenier V, Thinard R, Baron D, Charpentier M, Renaud JB, Buelow R, Cost GJ, Giovannangeli C, Fraichard A, Concordet JP, Anegon I.

Genome Res. 2014 Aug;24(8):1371-83. doi: 10.1101/gr.171538.113. Epub 2014 Jul 2.

18.

Gene targeting in rats using transcription activator-like effector nucleases.

Ménoret S, Tesson L, Rémy S, Usal C, Thépenier V, Thinard R, Ouisse LH, De Cian A, Giovannangeli C, Concordet JP, Anegon I.

Methods. 2014 Aug 15;69(1):102-7. doi: 10.1016/j.ymeth.2014.02.027. Epub 2014 Feb 28.

PMID:
24583114
19.

Generation of TALEN-mediated GRdim knock-in rats by homologous recombination.

Ponce de León V, Mérillat AM, Tesson L, Anegón I, Hummler E.

PLoS One. 2014 Feb 11;9(2):e88146. doi: 10.1371/journal.pone.0088146. eCollection 2014.

20.

Technical advances in the generation of transgenic animals and in their applications. Nantes, France, June 7th 2013.

Ménoret S, Tesson L, Rémy S, Thinard R, Usal C, Ouisse LH, Thepenier V, Anegon I.

Transgenic Res. 2013 Oct;22(5):1065-72. doi: 10.1007/s11248-013-9736-1. Epub 2013 Aug 2. No abstract available.

PMID:
23907705
21.

Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases.

Ménoret S, Fontanière S, Jantz D, Tesson L, Thinard R, Rémy S, Usal C, Ouisse LH, Fraichard A, Anegon I.

FASEB J. 2013 Feb;27(2):703-11. doi: 10.1096/fj.12-219907. Epub 2012 Nov 12.

PMID:
23150522
22.

Effects of BCL-2 over-expression on B cells in transgenic rats and rat hybridomas.

Iscache AL, Ménoret S, Tesson L, Rémy S, Usal C, Pedros C, Saoudi A, Buelow R, Anegon I.

Int Immunol. 2011 Oct;23(10):625-36. doi: 10.1093/intimm/dxr071. Epub 2011 Sep 19.

PMID:
21930595
23.

Knockout rats generated by embryo microinjection of TALENs.

Tesson L, Usal C, Ménoret S, Leung E, Niles BJ, Remy S, Santiago Y, Vincent AI, Meng X, Zhang L, Gregory PD, Anegon I, Cost GJ.

Nat Biotechnol. 2011 Aug 5;29(8):695-6. doi: 10.1038/nbt.1940. No abstract available.

PMID:
21822240
24.

Effects of Human Alpha-Synuclein A53T-A30P Mutations on SVZ and Local Olfactory Bulb Cell Proliferation in a Transgenic Rat Model of Parkinson Disease.

Lelan F, Boyer C, Thinard R, Rémy S, Usal C, Tesson L, Anegon I, Neveu I, Damier P, Naveilhan P, Lescaudron L.

Parkinsons Dis. 2011;2011:987084. doi: 10.4061/2011/987084. Epub 2011 Jun 28.

25.

Characterization of immunoglobulin heavy chain knockout rats.

Ménoret S, Iscache AL, Tesson L, Rémy S, Usal C, Osborn MJ, Cost GJ, Brüggemann M, Buelow R, Anegon I.

Eur J Immunol. 2010 Oct;40(10):2932-41. doi: 10.1002/eji.201040939.

26.

New lines of GFP transgenic rats relevant for regenerative medicine and gene therapy.

Remy S, Tesson L, Usal C, Menoret S, Bonnamain V, Nerriere-Daguin V, Rossignol J, Boyer C, Nguyen TH, Naveilhan P, Lescaudron L, Anegon I.

Transgenic Res. 2010 Oct;19(5):745-63. doi: 10.1007/s11248-009-9352-2. Epub 2010 Jan 22.

PMID:
20094912
27.

Analysis by quantitative PCR of zygosity in genetically modified organisms.

Tesson L, Rémy S, Ménoret S, Usal C, Anegon I.

Methods Mol Biol. 2010;597:277-85. doi: 10.1007/978-1-60327-389-3_19.

PMID:
20013240
28.

Generation of gene-specific mutated rats using zinc-finger nucleases.

Geurts AM, Cost GJ, Rémy S, Cui X, Tesson L, Usal C, Ménoret S, Jacob HJ, Anegon I, Buelow R.

Methods Mol Biol. 2010;597:211-25. doi: 10.1007/978-1-60327-389-3_15.

PMID:
20013236
29.

The use of lentiviral vectors to obtain transgenic rats.

Remy S, Nguyen TH, Ménoret S, Tesson L, Usal C, Anegon I.

Methods Mol Biol. 2010;597:109-25. doi: 10.1007/978-1-60327-389-3_8.

PMID:
20013229
30.

Generation of transgenic rats by microinjection of short DNA fragments.

Ménoret S, Remy S, Usal C, Tesson L, Anegon I.

Methods Mol Biol. 2010;597:81-92. doi: 10.1007/978-1-60327-389-3_6.

PMID:
20013227
31.

"Transgenesis, recent technical developments and applications" Nantes, 8th June 2009.

Ménoret S, Tesson L, Remy S, Usal C, Iscache AL, Anegon I.

Transgenic Res. 2010 Aug;19(4):711-4. doi: 10.1007/s11248-009-9340-6. Epub 2009 Nov 1. No abstract available.

PMID:
19882223
32.

Zinc-finger nucleases: a powerful tool for genetic engineering of animals.

Rémy S, Tesson L, Ménoret S, Usal C, Scharenberg AM, Anegon I.

Transgenic Res. 2010 Jun;19(3):363-71. doi: 10.1007/s11248-009-9323-7. Epub 2009 Sep 26. Review.

PMID:
19821047
33.

Potential role of soluble ST2 protein in idiopathic nephrotic syndrome recurrence following kidney transplantation.

Bruneau S, Le Berre L, Hervé C, Valanciuté A, Kamal M, Naulet J, Tesson L, Foucher Y, Soulillou JP, Sahali D, Dantal J.

Am J Kidney Dis. 2009 Sep;54(3):522-32. doi: 10.1053/j.ajkd.2009.03.021. Epub 2009 Jun 10.

34.

Carbon monoxide inhibits TLR-induced dendritic cell immunogenicity.

Rémy S, Blancou P, Tesson L, Tardif V, Brion R, Royer PJ, Motterlini R, Foresti R, Painchaut M, Pogu S, Gregoire M, Bach JM, Anegon I, Chauveau C.

J Immunol. 2009 Feb 15;182(4):1877-84. doi: 10.4049/jimmunol.0802436.

35.

IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells.

Hill M, Tanguy-Royer S, Royer P, Chauveau C, Asghar K, Tesson L, Lavainne F, Rémy S, Brion R, Hubert FX, Heslan M, Rimbert M, Berthelot L, Moffett JR, Josien R, Grégoire M, Anegon I.

Eur J Immunol. 2007 Nov;37(11):3054-62.

36.

CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase.

Guillonneau C, Hill M, Hubert FX, Chiffoleau E, Hervé C, Li XL, Heslan M, Usal C, Tesson L, Ménoret S, Saoudi A, Le Mauff B, Josien R, Cuturi MC, Anegon I.

J Clin Invest. 2007 Apr;117(4):1096-106.

37.

Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase.

Hill M, Pereira V, Chauveau C, Zagani R, Remy S, Tesson L, Mazal D, Ubillos L, Brion R, Asghar K, Mashreghi MF, Kotsch K, Moffett J, Doebis C, Seifert M, Boczkowski J, Osinaga E, Anegon I.

FASEB J. 2005 Dec;19(14):1957-68. Erratum in: FASEB J. 2006 Jul;20(9):1573. Ashgar, Kashif [corrected to Asghar, Kashif].

PMID:
16319139
38.

Transgenic modifications of the rat genome.

Tesson L, Cozzi J, Ménoret S, Rémy S, Usal C, Fraichard A, Anegon I.

Transgenic Res. 2005 Oct;14(5):531-46. Review.

PMID:
16245144
39.

[Vascular beta-adrenergic remodeling in rat transgenic model over-expressing endothelial beta3-adrenoceptors].

Toumaniantz G, Seze C, Serpillon S, Menoret S, Tesson L, Anégone I, Gauthier C.

Arch Mal Coeur Vaiss. 2005 Jul-Aug;98(7-8):836-40. French.

PMID:
16220757
40.

Transgenic expression of CTLA4-Ig by fetal pig neurons for xenotransplantation.

Martin C, Plat M, Nerriére-Daguin V, Coulon F, Uzbekova S, Venturi E, Condé F, Hermel JM, Hantraye P, Tesson L, Anegon I, Melchior B, Peschanski M, Le Mauff B, Boeffard F, Sergent-Tanguy S, Neveu I, Naveilhan P, Soulillou JP, Terqui M, Brachet P, Vanhove B.

Transgenic Res. 2005 Aug;14(4):373-84.

PMID:
16201404
41.

Identification of a new member of the CD20/FcepsilonRIbeta family overexpressed in tolerated allografts.

Louvet C, Chiffoleau E, Heslan M, Tesson L, Heslan JM, Brion R, Bériou G, Guillonneau C, Khalife J, Anegon I, Cuturi MC.

Am J Transplant. 2005 Sep;5(9):2143-53.

42.

Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression.

Chauveau C, Rémy S, Royer PJ, Hill M, Tanguy-Royer S, Hubert FX, Tesson L, Brion R, Beriou G, Gregoire M, Josien R, Cuturi MC, Anegon I.

Blood. 2005 Sep 1;106(5):1694-702. Epub 2005 May 26.

43.

Characterization of human CD55 and CD59 transgenic pigs and kidney xenotransplantation in the pig-to-baboon combination.

Ménoret S, Plat M, Blancho G, Martinat-Botté F, Bernard P, Karam G, Tesson L, Renaudin K, Guillouet P, Weill B, Chéreau C, Houdebine LM, Soulillou JP, Terqui M, Anegon I.

Transplantation. 2004 May 15;77(9):1468-71.

PMID:
15167611
44.

Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer.

Braudeau C, Bouchet D, Tesson L, Iyer S, Rémy S, Buelow R, Anegon I, Chauveau C.

Gene Ther. 2004 Apr;11(8):701-10.

PMID:
14973545
45.

The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide.

Ashton-Chess J, Meurette G, Karam G, Petzold T, Minault D, Naulet J, Tesson L, Plat M, Anegon I, Soulillou JP, Blancho G.

Xenotransplantation. 2004 Mar;11(2):112-22.

PMID:
14962273
46.

The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection.

Guillonneau C, Louvet C, Renaudin K, Heslan JM, Heslan M, Tesson L, Vignes C, Guillot C, Choi Y, Turka LA, Cuturi MC, Anegon I, Josien R.

J Immunol. 2004 Feb 1;172(3):1619-29.

47.

Generation of heme oxygenase-1-transgenic rats.

Braudeau C, Bouchet D, Toquet C, Tesson L, Ménoret S, Iyer S, Laboisse C, Willis D, Jarry A, Buelow R, Anegon I, Chauveau C.

Exp Biol Med (Maywood). 2003 May;228(5):466-71.

PMID:
12709570
48.

Differential sensitivity of endothelial cells of various species to apoptosis induced by gene transfer of Fas ligand: role of FLIP levels.

Bouchet D, Tesson L, Ménoret S, Charreau B, Mathieu P, Yagita H, Duisit G, Anegon I.

Mol Med. 2002 Oct;8(10):612-23.

49.

Rapid selection of differentially expressed genes in TNF[alpha]-activated endothelial cells.

Nagasaka T, Boulday G, Fraser CC, Coupel S, Coulon F, Tesson L, Heslan JM, Soulillou JP, Charreau B.

Mol Med. 2002 Sep;8(9):559-67.

50.

Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection.

Chauveau C, Bouchet D, Roussel JC, Mathieu P, Braudeau C, Renaudin K, Tesson L, Soulillou JP, Iyer S, Buelow R, Anegon I.

Am J Transplant. 2002 Aug;2(7):581-92.

Supplemental Content

Loading ...
Support Center